Sykon Capital »

Perspective Therapeutics shares owned by Sykon Capital

Quarter-by-quarter ownership of Perspective Therapeutics shares owned by Sykon Capital from 13F filings

Historical chart of Sykon Capital investment in Perspective Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Perspective Therapeutics held by Sykon Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perspective Therapeutics by Sykon Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $378k 38k 9.97

More positions owned by Sykon Capital

Wisdomtree Tr Floatng Rat Trea (USFR)
Select Sector Spdr Tr Technology (XLK)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)
Ishares Tr Core Us Aggbd Et (AGG)
Spdr Ser Tr Portfolio Ln Tsr (SPTL)
Schwab Strategic Tr Long Term Us (SCHQ)
Select Sector Spdr Tr Financial (XLF)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Ishares Tr Msci Eafe Etf (EFA)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Spdr Ser Tr Bloomberg Invt (FLRN)
Proshares Tr Short Qqq (PSQ)
Ishares Tr Core S&p500 Etf (IVV)

View all positions for Sykon Capital

Top funds holding Perspective Therapeutics

Commodore Capital
Henderson Group
BlackRock
Avidity Partners Management
Vanguard Group
Deerfield Management Company
Octagon Capital Advisors
Marshall Wace
Geode Capital Management
State Street Corporation
Ghost Tree Capital
Paradigm Biocapital Advisors
Sphera Funds Management
Citadel Advisors
Affinity Asset Advisors

View all funds holding Perspective Therapeutics